In the mammalian nervous system, axons are commonly surrounded by myelin, a lipid-rich sheath that is essential for precise and rapid conduction of nerve impulses. In the peripheral nervous system (PNS), myelin sheaths are formed by Schwann cells which wrap around individual axons. While the tyrosine kinase receptors ERBB2 and ERBB3 are established mediators of peripheral myelination, less is known about the functions of the related epidermal growth factor receptor (EGFR) in the regulation of PNS myelination. Here, we report a peripheral neurodegenerative disease caused by increased EGFR activation. Specifically, we characterize a symmetric and distally pronounced, late-onset muscular atrophy in transgenic mice overexpressing the EGFR ligand epigen. Histological examination revealed a demyelinating neuropathy and axon degeneration, and molecular analysis of signaling pathways showed reduced protein kinase B (PKB, AKT) activation in the nerves of Epigen-tg mice, indicating that the muscular phenotype is secondary to PNS demyelination and axon degeneration. Crossing of Epigen-tg mice into an EGFR-deficient background revealed the pathology to be completely EGFR-dependent. This mouse line provides a new model for studying molecular events associated with early stages of peripheral neuropathies, an essential prerequisite for the development of successful therapeutic interventions.
Introduction
In the mammalian nervous system, axons are frequently surrounded by myelin, a lipid-rich sheath that is essential for precise and rapid conduction of nerve impulses and for protection against axonal damage. Myelin sheath formation and maintenance underlies a complex signaling crosstalk between axons and oligodendrocytes (in the central nervous system, CNS) or axons and Schwann cells (in the peripheral nervous system, PNS) [1] . In both cases, the myelinating cell wraps a specialized plasma membrane multiple times around the axon. Notably, the number of wraps (and consequently the myelin thickness) is proportional to the axon diameter, highlighting the strong interaction between the two cell types [2] . Precise myelination is a critical process, and its deregulation results in numerous severe neurological diseases, including multiple sclerosis and peripheral neuropathies.
Over the recent years, much has been learned about the specific signaling pathways regulating Schwann cell development and the maintenance of myelin sheaths in the PNS throughout life [3] [4] [5] . A number of studies, based mainly on the phenotypes of genetically modified mouse models, revealed that neuregulin-1 (NRG1) provides a key axonal signal that regulates Schwann cell proliferation, migration, and myelination (reviewed in [6] ). For example, reduced NRG1 expression causes hypomyelination and decreases nerve conduction velocity, while neuronal overexpression of NRG1 induces hypermyelination [7] . NRG1 effects are mediated by Schwann cell-based ERBB2/3 receptor tyrosine kinases, whose loss causes severe defects in early Schwann cell development [8, 9] . These receptors belong to the broad EGFR/ ERBB signaling pathway, which exerts multiple actions in development, tissue homeostasis, and disease [10, 11] .
The epidermal growth factor receptor (EGFR) has been implicated in the myelination of the central nervous system [12] and in the expansion of peripheral nervous system progenitor cells, including Schwann cell precursors [13] . However, in contrast to ERBB2/3, the EGFR is not considered a major player in the myelination process. In this study, we report a symmetric and distally pronounced, late-onset muscular atrophy in transgenic mice overexpressing the EGFR ligand epigen. The neuropathy is secondary to PNS demyelination and axon degeneration, and is fully EGFR-dependent.
Materials and methods

Animal models
The generation of Epigen-tg mice has been described in detail previously [14] . Egfr Wa5/+ mice (Wa5) expressing an antimorphic Egfr allele [15] 
SHIRPA-protocol
Transgenic and control mice were examined according to a slightly modified SHIRPA observational test [16, 17] .
Tissue preparation
Muscles and nerves were dissected according to their location described in a mouse anatomic atlas [18] . Muscles were blotted dry and weighed to the nearest milligram.
RNA expression analysis
Nerve fibers were homogenized in TRIzol® (Invitrogen, Karlsruhe, Germany) for RNA isolation and 1 μg of RNA was reverse-transcribed in a final volume of 35 μl using Superscript™ II Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. For qualitative mRNA expression of murine and transgenic (human) Epgn/EPGN, RT-PCR using reagents from Qiagen (Hilden, Germany) was performed. The final reaction volume was 20 μl, and cycle conditions were 94°C for 5 min, followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min. The primers employed were: murine Epgn forward primer 5′-ACTACATAGAAGAACCTGTAGC-3′ and reverse primer 5′-GCTTGATGACTATGTCTTATAAG-3′; human EPGN forward primer 5′-TTTGGGAGTTCCAATATCAGC-3′ and reverse primer 5′-TGTGATTGGAGGTGTTACAGTCA-3′; and Gapdh forward primer 5′-TCATCAACGGGAAGCCCATCAC-3′ and reverse primer 5′-AGACTCCA CGACATACTCAGCACCG-3′.
Quantitative mRNA expression analysis was performed by realtime quantitative RT-PCR using the LightCycler® 480 System and the LightCycler® 480 Probes Master (Roche, Mannheim, Germany). Final primer concentration was 0.5 μM and probe concentration was 0.2 μM. The final reaction volume was 10 μl, and cycle conditions were 95°C for 5 min followed by 45 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C for 1 s. Quantitative values are obtained from the Ct number at which the increase in the signal associated with the exponential growth of PCR products begins to be detected. Transcript copy numbers were normalized to Actb mRNA copies. Results are expressed as fold differences in target gene expression relative to Actb transcripts. The ΔCt value of the sample was determined by subtracting the average Ct value of the target gene from the average Ct value of the Actb gene. Probes were labeled with the reporter dye FAM at the 5′ and the quencher dye TAMRA at the 3′ end. For each primer pair, we performed no-template control and no-RT control assays, which produced negligible signals that were usually greater than 40 in their Ct value. Experiments were performed in duplicates for each sample. Sequences of primers (Thermo Fisher Scientific, Dreieich, Germany) and probes (Roche) for the evaluated transcripts are shown in Table 1 .
Western blot analysis
For protein extraction, tissue samples were homogenized in Laemmli-extraction-buffer, and the protein content was estimated by the bicinchoninic acid (BCA) protein assay. 20 μg of total protein was separated by 8% or 12% SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, USA) by electroblotting. Membranes were washed in Tris-buffered saline solution with 0.1% Tween-20 (TBS-T) and blocked in 5% w/v fat-free milk powder for 1 h at room temperature. Membranes were washed again in TBS-T and incubated in 5% w/v BSA of the appropriate primary antibody overnight at 4°C. All primary antibodies are shown in Table 2 . After washing, membranes were incubated in 5% w/v fat-free milk powder with a horseradish peroxidase-labeled secondary antibody (donkey anti-rabbit; 1:2000; NA934V; GE-Healthcare, Munich, Germany or rabbit antimouse; 1:2000; #7076; Cell Signaling, Frankfurt, Germany) for 1 h at room temperature. Bound antibodies were detected using an enhanced chemiluminescence detection reagent (ECL Advance Western Blotting Detection Kit, GE Healthcare) and appropriate X-ray films (GE Healthcare). After detection, membranes were stripped by incubation with an appropriate buffer (2% SDS, 62.5 mM Tris/HCl, pH 6.7 and 100 mM β-mercaptoethanol) for 40 min at 70°C and incubated with a second primary antibody recognizing the total protein of a phosphorylated protein or a housekeeper protein.
Immunoprecipitation has been described elsewhere [19] . Briefly, 200 μg of protein samples was incubated with 2 μg rabbit anti-EGFR antibodies for 3 h at 4°C in an overhead shaker. 25 μl of protein A magnetic beads (Cell Signaling) was then added for 2 additional hours. The immune complex was washed in PBS and resuspended in 1× Laemmli protein extraction buffer. After denaturation, the samples were separated in an 8% SDS-PAGE and blotted to PVDF membranes as described above. The level of receptor phosphorylation was analyzed with antibodies shown in Table 2 . Membranes were stripped and incubated with an antibody recognizing the total receptor.
Histology and morphometric analysis
Muscles were fixed for 24 h in fresh 4% paraformaldehyde (in PBS) at 4°C, dehydrated in a graded alcohol series and embedded in paraffin. Paraffin sections were H&E-stained under standard conditions. 
Forward primer Reverse primer Fluorogenic probe 5′-GATGAGAAGTCCTCTTTCATCTGTAAC-3′ 5′-GGTCATAGCAGACGCTGTTG-3′ 5′-CTCCAGCC-3′ Nerves were frozen in OCT and sectioned (8 μm) using a cryostat. Sections were fixed in 4% paraformaldehyde in PBS for 15 min, followed by Masson trichrome staining using a standard protocol.
Nerves were stretched on a blotting paper and immersed in 2.5% glutaraldehyde in Soerensen's phosphate buffer (pH 7.4) for 1 h. Soerensen's phosphate buffer was subsequently used to rinse the fixed nerve segments. Transverse segments with a length of 2 mm were cut and post-fixed in 2% OsO 4 for 2 h. Repeated Soerensen's phosphate buffer rinses and a graded alcohol series were carried out before the segments were embedded in epoxy resin. For microscopic and morphometric evaluations, semithin sections (0.5 μm) were mounted on triethoxysilane-coated slides and stained with azur II-methylene blue-safranin. For electron microscopy, ultrathin sections (80 nm) were contrasted with uranyl acetate and lead citrate. Specimens were assessed via Zeiss-EM10 (Germany).
Morphometric analysis was done as described elsewhere [20] . Briefly, for muscle fiber and nuclei analysis every fifth visual field was evaluated using a counting frame. Starting from a random point outside the tissue, each section was examined as a series of vertical and horizontal parallel stripes at 400× magnification. All muscle fibers and nuclei within the visual field were counted, except for those touching the right-hand and lower lines of the field. Leica LAS software V3.8.0 (Leica Microsystems, Heerbrugg, Switzerland) was used for area calculation.
For g-ratio analysis, four semithin sections per animal and nerve were evaluated in the following manner: starting from a random point outside the tissue, each section was examined as a series of vertical and horizontal parallel stripes at 1000× magnification. Every third visual field covering nerve tissue was selected for measuring axon area and myelin area of any myelinated fiber using Leica LAS software V3.8.0. All fibers in the visual field were measured, except for those touching the right-hand and lower lines of the field. G-ratio was calculated by the quotient of axon area/fiber area.
For myelin area analysis, the blue-stained areas of six semithin sections per animal and nerve were measured via Leica LAS software V3.8.0.
Statistical analysis
Data are presented as means ± SD or box-plots with median (quantitative RT-PCR). SHIRPA data are presented as means ± SEM. Quantitative RT-PCR values were related to the mean value of the control group and compared by Mann-Whitney U-tests (GraphPad Prism, GraphPad Software, San Diego, USA). The remaining data were analyzed with Student's t-test. P b 0.05 was considered statistically significant.
Results
Overexpression of epigen causes a late-onset muscular atrophy
We recently reported that transgenic mice with ubiquitous overexpression of human epigen, a poorly characterized EGFR ligand [21, 22] , show hyperproliferation of the skin and its appendages [14] . Long-term observation of Epigen-tg animals revealed symptoms of impaired neuromuscular function, first observable at 4-6 months of age and including trembling and atony of the hind limbs as demonstrated by enhanced limb-clasping reflex when suspended by the tail (Fig. 1A) . A SHIRPA analysis confirmed impairment in motor and proprioceptive function (Fig. 1B) . Both male and female Epigen-tg mice at different ages showed a significant reduction in total body weight and carcass weight, indicating decreased muscle mass (Supplementary Fig. 1 ). Evaluation of the absolute weight of the triceps muscle revealed a significant reduction in Epigen-tg females as compared to control, gendermatched littermates, but the reduction turned out to be allometric (proportional to the change in total body weight, Supplementary  Fig. 1A ). In contrast, the significant reduction in the absolute weight of the quadriceps muscle was maintained when expressed in relation to total body weight ( Supplementary Fig. 1A) , indicating a more severe impairment of hind limb muscles as compared to those of the front limb (see also Supplementary Fig. 2 ). Since the same effect was observed in males ( Supplementary Fig. 1B ) a gender-specific effect is unlikely and further examinations were carried out in females only. Histological analysis revealed no changes in the tissue architecture of the triceps muscle in 2-month-old and 10-month-old Epigen-tg mice, whereas small areas of fatty degeneration and a prominent fiber size variation were observed in 18-month-old transgenic animals ( Fig. 2A) . At this age, the triceps muscle showed several partially grouped atrophic, angular fibers and satellite cells. In contrast, satellite cells were readily observable in the quadriceps muscle of 2-month-old Epigen-tg mice ( Fig. 2A) . Furthermore, an age-dependent increase in fiber size variation with augmented numbers of angular fibers and internalized nuclei was seen in the quadriceps muscle of older animals ( Fig. 2A) . Muscle fiber hypertrophy and central nucleation are indicative of secondary myopathic changes, potentially related to ongoing denervation [23] . Quantitative analysis revealed a significant increase in the density of nuclei and a decrease in the mean fiber area in the quadriceps but only a trend in the triceps of 10-month-old transgenic mice (Fig. 2B) . Next, to assess fiber type grouping, we carried out immunohistochemistry to detect type II myosin in the quadriceps and triceps muscles. At the age of 2 months, type I fibers were restricted to a small area at the periphery of the quadriceps muscle and corresponded to 1.33 ± 0.1% of fibers in control and 1.14 ± 0.09% of fibers in transgenic mice (P = 0.14). At the age of 10 months, a comparable number of type I fibers were still visible at the periphery of the quadriceps in control mice, whereas only type II fibers were detected in the quadriceps muscle of transgenic mice. A similar picture was observed in the triceps muscle (data not shown). Therefore, while fiber type grouping can be excluded at the age of 2 months, the loss of type I fibers at the age of 10 months suggests fiber grouping. Nevertheless, a classical picture of fiber grouping, as would be seen in a mixed muscle, cannot be proven by immunohistochemistry in Epigen-tg mice since in both control and transgenic mice the quadriceps and triceps muscles were composed almost exclusively by type II muscle fibers, which is in accordance to previously published data for rodents [24, 25] . To exclude differences in the regional expression of the transgene as the reason for these observations, we evaluated the presence of transgene-derived epigen transcripts in different tissues by RT-PCR. Transgene expression was detected in the cervical, thoracic, and lumbar spinal cord and in the peripheral radial and femoral nerves, as well as in the triceps and quadriceps muscles (Supplementary Fig. 3 ). Taken together, these findings suggest a neuronal origin of the muscular atrophy.
The muscle atrophy is due to a demyelinating neuropathy
Having established a probable neuronal origin of the muscle atrophy, we next evaluated the presence of histological changes in the central and peripheral nervous systems of Epigen-tg mice and control littermates at the ages of 2, 10, or 18 months. No changes in tissue architecture could be seen in H&E-stained transversal sections of the brain and spinal cord (data not shown). In contrast, the femoral nerve showed a demyelinating neuropathy with a prominent reduction of Fig. 3 . Epigen-tg mice show a peripheral neuropathy characterized by demyelination and axon degeneration. Note the early neuropathy in the femoral nerve of transgenic mice, characterized by reduced axonal diameters, final naked axons, and severely reduced fiber density. Only clear thinning of the myelin sheath in comparison to axon diameter was rated as real demyelination, whereas myelin disintegration was interpreted as a processing artifact. Scale bars indicate 20 μm.
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axon diameters and signs of axon degeneration, which was already detectable at the age of 2 months and increased in severity with age (Fig. 3) . A similar although considerably milder neuropathy could be recognized in the radial nerve of 18-month-old transgenic animals (Fig. 3) . Quantitative analysis carried out in 10-month-old mice supported these observations, revealing significant reductions in the numbers of axons per nerve (Fig. 4A ) and per area (Fig. 4B) , in myelin area (Fig. 4C) , and in the mean axon diameter (Fig. 4D) in the femoral nerve, but only negligible changes in the radial nerve of Epigen-tg animals. Next, we evaluated the myelin sheath thickness by determining the g-ratio [26] . The average g-ratio in the radial nerve did not differ between genotypes (Fig. 4E) . In contrast, the g-ratio tended to be higher in the femoral nerve of Epigen-tg mice (Fig. 4E) , indicating that their myelin sheaths were thinner as compared to those of control animals. Electron microscopy revealed de-and remyelinating processes next to naked axons and the presence of single intratubular macrophages ( Supplementary Fig. 4 ) being especially pronounced in the femoral nerve of 18-month-old Epigen-tg mice.
Next, we focused on the activity of typical signaling pathways associated with the myelination process. Mitogen-activated protein kinase (MAPK1/2) and AKT1 are the major signaling pathways employed by ERBB2/3 to modulate Schwann cell myelination [27, 28] , and AKT1 is essential for correct myelination in the PNS [29] . While we failed to detect any changes in MAPK1/2 activation in the nerves of Epigen-tg mice independently of their site, we observed a clear reduction in the activation of AKT1 in the radial nerve and a complete abrogation of AKT1 activation in the femoral nerve (Fig. 5) . Evaluation of other signaling (mitogen-activated protein kinase 8/9 (MKD8/9), protein kinase C alpha (KPCA)) or structural (E-cadherin (CADH1), N-cadherin (CADH2), myelin protein P0 (Mpz), myelin basic protein (Mbp), connexin-32 (Gjb1)) molecules known to regulate myelination failed to reveal any changes in Epigen-tg mice as compared to control animals ( Supplementary Fig. 5 ).
Collectively, these findings indicate that the muscle atrophy in Epigen-tg mice is a consequence of a demyelinating neuropathy.
The muscular phenotype and the neuropathy are EGFR-dependent
Western blot analysis readily revealed a stronger phosphorylation of tyrosine residues of the EGFR in the radial and femoral nerves of Epigentg mice as compared to control animals (Fig. 6A) . However, since a peripheral neuropathy similar to the phenotype of Epigen-tg mice has not been previously described in transgenic models overexpressing other EGFR ligands [30] , we next asked whether these changes are indeed mediated by the EGFR. To clarify this point, we crossed Epigen-tg mice with Wa5 animals, an ENU-derived mutant line expressing an antimorphic EGFR [15] . The Wa5 allele completely rescued the reduction in carcass weight (Fig. 6B) as well as the absolute and relative weight of the quadriceps muscle (Fig. 6C) . Furthermore, the histological changes of the quadriceps muscle (Fig. 6D ) and of the femoral nerve ( Fig. 6E ) of 10-month-old Epigen-tg mice were rescued in the presence of the Wa5 allele. These data strongly indicate that the described phenotype is EGFR-dependent.
Increased deposition of extracellular matrix in the nerves of Epigen-tg mice
Since the EGFR is abundantly expressed in fibroblasts [31] , but only at low levels in adult Schwann cells [32] , we evaluated whether increased activation of the EGFR in fibroblasts possibly altered the deposition of extracellular matrix proteins. As shown in Fig. 7A , a Masson trichrome staining revealed increased levels of connective tissue in the femoral nerve of 10-month-old Epigen-tg mice as compared to control littermates. In accordance, Western blot analysis confirmed increased amounts of collagen IV in both the radial and the femoral nerves of Epigen-tg mice as compared to control littermates (Fig. 7B ).
Discussion
Here, we report a symmetric and distally pronounced muscular atrophy of rather late onset in transgenic mice overexpressing epigen, the last identified EGFR ligand [30] , and characterize its pathogenesis. Epigen, originally identified during high throughput sequencing of a mouse keratinocyte library [21] , is expressed in several organs and is a potent mitogen in spite of having a low affinity to the EGFR [22] . Only limited information about epigen exists, including its detection as a protein overexpressed in human cancer specimens [33, 34] , its identification as a target of LH/hCG in mouse granulosa cells [35] , of interleukin-13 in primary airway epithelial cells [36] , and of ectodysplasin in the skin [37] and mammary gland [38] . Epigen also appears to play a role in sebaceous glands [14, 39] . In contrast, among the family of EGFR ligands, epigen was shown to play a minor role in the pathogenesis of malignant peripheral nerve sheath tumors [40] . Mice lacking epigen develop and grow normally, probably due to functional compensation by the remaining EGFR ligands [41] .
Histological examination and molecular analysis of signaling pathways indicate that the muscular phenotype of Epigen-tg mice is secondary to PNS demyelination and axon degeneration. In a classical genetic experiment, we also show that the phenotype is completely EGFRdependent. However, while the histological changes in the muscles of Epigen-tg mice strongly suggest pathology of neuronal origin, a concomitant primary myopathic process cannot be fully excluded. To our knowledge, this is the first report of a peripheral neuropathy in association with EGFR hyperactivation. The fact that the EGFR is not expressed in adult Schwann cells [32] suggested that the mechanism behind the peripheral neuropathy is possibly Schwann cell extrinsic. To explore the possibility that the phenotype is mediated by fibroblasts of the endoneurium and perineurium, cells known to carry the EGFR [31] , we evaluated the abundance of extracellular matrix proteins. Indeed, we could readily detect fibrosis and increased levels of collagen IV in the nerves of Epigen-tg mice.
While we cannot offer a definitive proof for fibroblast-mediated alterations of the ECM composition as the cause of the reported pathology, there are several facts supporting such a mechanism. First, although the regulatory impact of nerve fibroblasts has received little attention so far, it is known that these cells can influence Schwann cell behavior in different ways [42] . One of the most important functions of endoneurium fibroblasts is the secretion of ECM, a complex network of secreted proteins that provides mechanical support to the resident cells and promotes axon-Schwann cell interactions [43, 44] . Second, changes in the composition of endoneurial ECM have been described in a large number of human peripheral neuropathies [45] , the peripheral neuropathy of the twitcher mouse, a model for human globoid leukodystrophy, is associated with massive changes in the ECM of the endoneurium [46, 47] , and mice lacking basal lamina components such as laminin α2 chain [48, 49] or β1 integrin [50] show a severe neuropathy and represent models of congenital muscular dystrophy. Third, increased levels of other EGFR ligands such as transforming growth factor-α or amphiregulin have been reported to result in fibrosis in several organs, including the lung [51, 52] , the exocrine [53] , and the endocrine pancreas [54] .
Interestingly, the phenotype of Epigen-tg mice resembles some subtypes of Charcot-Marie-Tooth (CMT) disease, a genetically heterogeneous disorder and the most common inherited neurologic disease in humans [55] . CMT1A, the most frequent form of CMT, is caused by increased PMP22 expression due to a chromosomal duplication at 17p11.2 [55] . Transgenic mice engineered to overexpress human [56] or mouse [57] PMP22 show early-onset (~3 weeks of age) neurological disorders and a shortened lifespan, dying before 5 months of age. Notably, in at least one of these lines, PMP22 overexpression was shown to enhance collagen synthesis by fibroblasts prior to myelination [58] . The neuropathy of Epigen-tg mice also bears some similarities to that of periaxin-deficient mice [59] , a model of CMT4F.
In conclusion, we describe for the first time a peripheral demyelinating neuropathy as a consequence of increased EGFR activation. Our data suggest that the pathogenic mechanism is related to increased deposition of extracellular matrix, possibly due to the activation of the EGFR in endoneurium fibroblasts of Epigen-tg mice. Due to the rather late onset and slow progression of the disease, we believe that Epigen-tg mice are an appealing model for studying molecular events associated with early stages of peripheral neuropathies, an essential prerequisite for the development of successful therapeutic interventions. Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.bbadis.2013.07.011.
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